DDS Form 144: Holder plans NYSE sale of 750 shares via Raymond James

Rhea-AI Filing Summary

Dillard’s (DDS): Notice of proposed insider sale. A holder filed a Form 144 to sell up to 750 shares of Dillard’s common stock. The filing lists an aggregate market value of $442,024.80 and an approximate sale date of October 16, 2025. The shares are slated to be sold on the NYSE through Raymond James & Associates.

The shares to be sold were acquired via stock awards from the issuer on three dates: 400 shares on May 20, 2024, 100 shares on May 19, 2023, and 250 shares on May 22, 2017, with cash noted as the form of payment at acquisition.

The signer represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RAYMOND JAMES & ASSOCIATES 880 CARILLON PARKWAY ST. PETERSBURG FL 33716	750	442024.80	11626733	10/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	05/20/2024	STOCK AWARD	ISSUER			400	05/20/2024	CASH
COMMON	05/19/2023	STOCK AWARD	ISSUER			100	05/23/2024	CASH
COMMON	05/22/2017	STOCK AWARD	ISSUER			250	05/22/2017	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Dillard’s (DDS) disclose in this Form 144?

A holder filed notice of intent to sell up to 750 Dillard’s common shares on or about October 16, 2025 on the NYSE via Raymond James.

What is the aggregate market value of the proposed DDS share sale?

The filing states an aggregate market value of $442,024.80 for the proposed sale.

Where and through whom may the DDS shares be sold?

The shares may be sold on the NYSE through Raymond James & Associates.

What is the source of the DDS shares listed for sale?

They were acquired via stock awards from the issuer on May 20, 2024 (400), May 19, 2023 (100), and May 22, 2017 (250).

Does the Form 144 include a representation about undisclosed information?

Yes. The signer represents they do not know any material adverse information about the issuer that hasn’t been publicly disclosed.

How many DDS shares are proposed to be sold under this notice?

The notice covers up to 750 common shares.